End-stage Renal Disease Costs for Patients New to Hemodialysis in Italy: The FARO-2 Study
Daniela Paola Roggeri, Alessandro Roggeri, Diego Brancaccio, Sandro Mazzaferro, Piergiorgio Messa, Ernesto Paoletti, Alessandro Possidoni, Anna Maria Costanzo, Umberto di Luzio Paparatti, Mario Cozzolino & On behalf of the FARO-2 Study Group · Journal of Advances in Medicine and Medical Research · 2015
Background: Increasing incidence and prevalence of end-stage renal disease (ESRD) together with the presence of several comorbidities in chronic kidney disease patients (CKD) could be associated with a relevant economic burden. Aim: The aim of this analysis was to estimate the di...
Open access
Research Article
10.9734/BJMMR/2016/22222